Akila Prashant

15.9k total citations · 1 hit paper
78 papers, 572 citations indexed

About

Akila Prashant is a scholar working on Epidemiology, Endocrinology, Diabetes and Metabolism and Molecular Biology. According to data from OpenAlex, Akila Prashant has authored 78 papers receiving a total of 572 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Epidemiology, 12 papers in Endocrinology, Diabetes and Metabolism and 11 papers in Molecular Biology. Recurrent topics in Akila Prashant's work include Diabetes, Cardiovascular Risks, and Lipoproteins (6 papers), Sepsis Diagnosis and Treatment (5 papers) and Respiratory Support and Mechanisms (4 papers). Akila Prashant is often cited by papers focused on Diabetes, Cardiovascular Risks, and Lipoproteins (6 papers), Sepsis Diagnosis and Treatment (5 papers) and Respiratory Support and Mechanisms (4 papers). Akila Prashant collaborates with scholars based in India, United States and Sweden. Akila Prashant's co-authors include Vivian D’Souza, Praveen Kulkarni, Chandini Rangaswamy, SubbaRao V. Madhunapantula, Divya P. Kumar, Kuzhuvelil B. Harikumar, P A Mahesh, Bojan Nataraj, Thuppil Venkatesh and Swapna Upadhyay and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Molecules.

In The Last Decade

Akila Prashant

61 papers receiving 543 citations

Hit Papers

Multidrug-Resistant Sepsis: A Critical Healthcare Challenge 2024 2026 2025 2024 10 20 30 40 50

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Akila Prashant India 12 105 102 64 63 57 78 572
Rüstem Anıl Uğan Türkiye 13 153 1.5× 118 1.2× 32 0.5× 49 0.8× 44 0.8× 32 632
Ali Beytur Türkiye 17 92 0.9× 84 0.8× 53 0.8× 104 1.7× 85 1.5× 48 783
Adil Aldhahrani Saudi Arabia 16 152 1.4× 61 0.6× 34 0.5× 41 0.7× 49 0.9× 52 658
Jawwad Ahmad Saudi Arabia 17 127 1.2× 65 0.6× 42 0.7× 43 0.7× 28 0.5× 30 667
Avinash Math India 5 123 1.2× 102 1.0× 28 0.4× 35 0.6× 52 0.9× 8 644
Shivaraj Gowda India 7 131 1.2× 108 1.1× 38 0.6× 35 0.6× 54 0.9× 11 686
Alena Tichá Czechia 15 152 1.4× 97 1.0× 42 0.7× 59 0.9× 142 2.5× 81 769
Prakash B Desai India 8 138 1.3× 104 1.0× 43 0.7× 35 0.6× 61 1.1× 9 740
Mengshi Yi China 9 115 1.1× 69 0.7× 76 1.2× 41 0.7× 41 0.7× 17 605
Di Zhou China 16 189 1.8× 62 0.6× 51 0.8× 59 0.9× 55 1.0× 36 786

Countries citing papers authored by Akila Prashant

Since Specialization
Citations

This map shows the geographic impact of Akila Prashant's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Akila Prashant with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Akila Prashant more than expected).

Fields of papers citing papers by Akila Prashant

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Akila Prashant. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Akila Prashant. The network helps show where Akila Prashant may publish in the future.

Co-authorship network of co-authors of Akila Prashant

This figure shows the co-authorship network connecting the top 25 collaborators of Akila Prashant. A scholar is included among the top collaborators of Akila Prashant based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Akila Prashant. Akila Prashant is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Prashant, Akila, et al.. (2024). Inflammaging in Multidrug-Resistant Sepsis of Geriatric ICU Patients and Healthcare Challenges. Geriatrics. 9(2). 45–45. 3 indexed citations
2.
Prashant, Akila, et al.. (2024). Efficacy of Clinical Tests in the Diagnosis of Meralgia Paresthetica: A Case Control Study. SHILAP Revista de lepidopterología. 2024(1). 5191280–5191280.
3.
Prashant, Akila, et al.. (2024). Unveiling the Significance of Surrogate Markers of Insulin Resistance in Metabolic Health Assessment. SHILAP Revista de lepidopterología. 28(2). 45–53. 1 indexed citations
4.
Prashant, Akila, et al.. (2024). Multidrug-Resistant Sepsis: A Critical Healthcare Challenge. Antibiotics. 13(1). 46–46. 57 indexed citations breakdown →
6.
Prashant, Akila, et al.. (2023). Sigma-Metric Analysis to Evaluate Quality Management of Analytical Processes Using RCA and QGI in a Clinical Biochemistry Laboratory, South India. International Journal of Health & Allied Sciences. 11(3). 1 indexed citations
7.
Prashant, Akila, et al.. (2023). AATF inhibition exerts antiangiogenic effects against human hepatocellular carcinoma. Frontiers in Oncology. 13. 1130380–1130380. 7 indexed citations
8.
Prashant, Akila, et al.. (2023). Assessing the diagnostic potential of 16SrRNA gene for neonatal sepsis: A tertiary care hospital study in South India. Medical Journal Armed Forces India. 80(6). 695–701.
9.
Singh, Pranav Kumar, Akila Prashant, Chandan Shivamallu, et al.. (2022). Preparation, Characterization and In Vitro Biological Activities of New Diphenylsulphone Derived Schiff Base Ligands and Their Co(II) Complexes. Molecules. 27(23). 8576–8576. 10 indexed citations
10.
Parthasarathi, Ashwaghosha, Jayaraj Biligere Siddaiah, Akila Prashant, et al.. (2022). Impact of Acute Exacerbation and Its Phenotypes on the Clinical Outcomes of Chronic Obstructive Pulmonary Disease in Hospitalized Patients: A Cross-Sectional Study. Toxics. 10(11). 667–667. 5 indexed citations
11.
Kumar, Naveen, et al.. (2021). N'-((3-(substituted phenyl)-1-phenyl-1H-Pyrazol-4-yl)methylene)-(substituted) benzhydrazide: Synthesis, characterization and pharmacological evaluation. Chemical Data Collections. 32. 100665–100665. 5 indexed citations
12.
Prashant, Akila, et al.. (2021). Chemopreventive and Anticancer Property of Selenoproteins in Obese Breast Cancer. Frontiers in Pharmacology. 12. 618172–618172. 25 indexed citations
14.
Prashant, Akila, et al.. (2020). Impact of experiential learning among medical undergraduates: A randomized controlled trial. Journal of Education and Health Promotion. 9(1). 306–306. 2 indexed citations
16.
Prashant, Akila, et al.. (2017). Fifty Percent Ethanolic Extract of Momordica charantia Inhibits Adipogenesis and Promotes Adipolysis in 3T3-L1 Pre-Adipocyte Cells.. PubMed. 6(1). 22–32. 10 indexed citations
17.
Prashant, Akila, et al.. (2015). Assessment of serum trace metals and body mass indices in rural and urban healthy adult population: A pilot study. International Journal of Health & Allied Sciences. 4(2). 89.
18.
Prashant, Akila, et al.. (2012). Exploration of the Clinico-Biochemical Parameters to Explain the Altered Renal Mechanisms in Gestational Diabetes Mellitus. SHILAP Revista de lepidopterología. 6 indexed citations
19.
Prashant, Akila, et al.. (2012). A retrospective analysis of serial measurement of serum cholinesterase in acute poisoning with organophosphate compounds. Toxicology International. 19(3). 255–255. 17 indexed citations
20.
Prashant, Akila, et al.. (2011). Prediction of outcome and prognosis of patients on mechanical ventilation using body mass index, SOFA score, C-Reactive protein, and serum albumin. Indian Journal of Critical Care Medicine. 15(2). 82–87. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026